Search results
Biomarkers for Congestion in Heart Failure
Author(s):
Antonio Luca Maria Parlati
,
Cristina Madaudo
,
Vincenzo Nuzzi
,
et al
Added:
1 year ago
Review Article
e-SPACE Heart Failure 2025 – Day Two
Author(s):
William T Abraham, Lisa Anderson, Stefan Anker
Start date:
Oct 18, 2025
Broadcast
e-SPACE Heart Failure 2025 – Day One
Author(s):
William T Abraham, Lisa Anderson, Stefan Anker
Start date:
Oct 17, 2025
Broadcast
SGLTi and GLP-1 in HF
Author(s):
Jose L Batista
,
Tracy Makuvire
,
Jonathan D Davis
,
et al
Added:
11 months ago
Review Article
Samuel Sherratt
Job title: Scientific Director
Author
Author(s):
Moza A Alzaabi
,
Amin Abdelsalam
,
Majid Alhammadi
,
et al
Added:
1 year ago
Author(s):
Javed Butler
Added:
1 year ago
Professor Javed Butler presents a routine case study of a HFrEF patient recently discharged from hospital for decompensated heart failure. The patient was treated with IV diuretics but now requires optimization of his on-going therapy, Professor Butler asks, ‘what should we do first?’.Follow the following links to watch further case studies on Worsening Heart Failure presented by Gianluigi…
View more
Added:
1 month ago
Source:
Arrhythmia Academy
Artificial intelligence applied to electrocardiograms (ECG-AI) may offer a scalable way to identify individuals at high risk of developing heart failure (HF), potentially improving on current clinical risk estimators, according to a new pooled cohort analysis from the HeartShare/Accelerating Medicines Partnership (AMP) Heart Failure program.¹The study aimed to assess whether ECG-AI models…
View more
Soledad García Hernández
Research Area(s) / Expertise:
Author
Author(s):
John JV McMurray
Added:
1 year ago
EASD 24 - We are joined by Professor John McMurray (University of Glasgow, UK) to discuss the key findings from a diabetes subgroup analysis of the FINEARTS-HF study.Interview Questions:1. What is the reasoning behind this analysis?2. What was the study design and patient cohort?3. What are the key findings?4. In your opinion, what can explain this risk reduction?5. What are the take-home…
View more